Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 245.81
+0.56 (0.23%)
Nov 12, 2026, 3:29 PM IST
Piramal Pharma Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Piramal Pharma stock has a consensus rating of "Strong Buy" and an average price target of ₹262.91. The average 1-year stock price forecast is 6.96% higher than the current stock price, while the lowest is ₹220.00 (-10.50%) and the highest is ₹300.00 (+22.05%).
Price Target: ₹262.91 (+6.96%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Piramal Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Apr '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 8 | 8 | 8 | 8 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 11 | 11 | 11 | 11 |
Financial Forecast
Revenue This Year
105.83B
from 88.69B
Increased by 19.32%
Revenue Next Year
119.63B
from 105.83B
Increased by 13.04%
EPS This Year
1.64
from -0.98
EPS Next Year
4.32
from 1.64
Increased by 162.91%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.